Journal of Cardiothoracic Surgery

FEBRUARY 14, 2025

Studies show conflicting results regarding the impact of the COVID-19 pandemic on the treatment of patients with coronary artery disease requiring cardiac surgery and data from Germany are lacking. In this stu.

COVID-19 52

COVID-19 Coronary Artery Disease Hospital Research 52

Open Heart

APRIL 20, 2022

Objective To assess the feasibility, efficacy and safety of performing exercise stress echocardiography (ESE) for the assessment of myocardial ischaemia during the COVID-19 pandemic. Of the 61 patients who underwent coronary angiography, 51 (83%) demonstrated flow-limiting coronary artery disease.

COVID-19 52

COVID-19 Exercise Coronary Artery Disease Echocardiogram 52

Coronary Artery Disease Journal

OCTOBER 31, 2023

Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. Patients with COVID-19 versus those without had significantly greater in-hospital mortality (45.2% reduction in admissions in 2020. vs. 10.7%; P < 0.001).

COVID-19 52

COVID-19 STEMI Inpatient Hospital 52

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. All COVID-19 hospitalizations with age ≥ 18 years were included in the analyses.

COVID-19 52

COVID-19 Myocardial Infarction Hospital ICU 52

Dr. Prateek Bhatnagar

SEPTEMBER 14, 2020

Prateek Bhatnagar, Director Cardiac Surgery & Chief Cardiology Surgeon at Care Hospital, Banjara Hills, Hyderabad, has successfully operated & discharged India’s first post Covid 19 recovered patient who on 16th July, 2020, underwent a triple bypass surgery under Dr. Bhatnagar & his team of doctors here.

COVID-19 52

COVID-19 Chest Pain Pulmonary Coronary Artery Disease 52

Coronary Artery Disease Journal

MAY 26, 2024

Background Patients with cardiovascular disease (CVD) and risk factors have increased rates of adverse events and mortality after hospitalization for coronavirus disease 2019 (COVID-19). All adult patients 18 years of age and older who were admitted with the primary diagnosis of COVID-19 were included.

COVID-19 40

COVID-19 Cardiovascular Disease Hospital Coronary Artery Disease 40

DAIC

APRIL 9, 2024

Diabetic cardiomyopathy is a disease in which chronically high levels of blood glucose (hyperglycemia) damage the heart muscle, leading to heart failure over time. However, the study launched shortly before the onset of the COVID-19 pandemic, which led to recruitment delays.

Heart Failure 52

Heart Failure Diabetes Cardiomyopathy Exercise 52